Topic: pharmacy benefit management
When it comes to addressing some of the biggest issues in healthcare, e-prescribing company Surescripts has a big potential role to play.
Democrats have officially revealed a plan to let people ages 50 and over buy in to Medicare, plus more insurance news.
CVS Caremark has put the brakes on a plan to cut payments to 340B providers—much to the joy of those hospitals.
Humana is expected to bleed a significant number of members from its Part D plans, as greater competition has chipped away at its market share.
PBMs are hitting back against critics who blame them for rising drug prices, as the system they use to negotiate rebates hangs in the balance.
Moody's Investors Service warned that Anthem's accelerated PBM launch could hurt Cigna's bottom line, plus more payer headlines.
The health system launched Ayin to help organizations transition from in-patient care to more cost-efficient ambulatory care and digital engagement.
The change would produce uncertain ricochets, including higher drug-plan premiums for consumers, resulting in winners and losers across the economy.
HHS Secretary Alex Azar is challenging Congress to take up the administration’s plan to end safe harbor protections for drug rebates.
Revenue, customer and earnings growth were driven by continued innovation across the business, said David Cordani, president and chief executive officer.